An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo

Shafaat A. Rabbani, Bushra Ateeq, Ani Arakelian, Maria Luisa Valentino, David E. Shaw, Lisa M. Dauffenbach, Christopher A. Kerfoot, Andrew P. Mazar

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences